av/astrazeneca--big.svg

NSE:ASTRAZEN

AstraZeneca Pharma India Limited

  • Stock

INR

Last Close

5,435.20

06/05 10:00

Market Cap

157.97B

Beta: 0.39

Volume Today

10.94K

Avg: 4.82K

PE Ratio

108.89

PFCF: 7,021.31

Dividend Yield

0.24%

Payout:0%

Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
net income
-5.09M
-
-208.40M
3,994.91%
57.64M
127.66%
332.05M
476.11%
438M
31.91%
726.70M
65.91%
1.14B
56.83%
1.27B
11.51%
830.40M
34.66%
1.34B
61.49%
depreciation and amortization
101.25M
-
152.81M
50.93%
174.26M
14.04%
158.26M
9.18%
147.40M
6.86%
149.20M
1.22%
185.80M
24.53%
197.50M
6.30%
169.50M
14.18%
162.60M
4.07%
deferred income tax
-14M
-
-319.20M
2,180%
-325M
1.82%
-317.50M
2.31%
stock based compensation
8.60M
-
9.50M
10.47%
11.20M
17.89%
14.80M
32.14%
18.20M
22.97%
23.71M
30.30%
change in working capital
176.59M
-
-325.78M
284.48%
420.95M
229.21%
-30.90M
107.34%
-342.50M
1,008.50%
98.10M
128.64%
-26.60M
127.12%
-39.50M
48.50%
328.90M
932.66%
-301.98M
191.82%
accounts receivables
-281.30M
-
-58.60M
79.17%
-45.70M
22.01%
-47.10M
3.06%
-236.30M
401.70%
inventory
-103.88M
-
96.27M
192.67%
94.01M
2.34%
190.12M
102.23%
-554.40M
391.61%
-49.60M
91.05%
-470.30M
848.19%
53.50M
111.38%
195.80M
265.98%
-499.95M
355.34%
accounts payables
552.70M
-
414.50M
25.00%
-313.40M
175.61%
96.70M
130.86%
374.40M
287.18%
other working capital
280.48M
-
-422.05M
250.48%
326.94M
177.46%
-221.02M
167.60%
211.90M
195.88%
-123.70M
158.38%
87.80M
170.98%
266.10M
203.08%
83.50M
68.62%
59.86M
28.31%
other non cash items
-280.83M
-
-75.64M
73.06%
-82.96M
9.68%
-76.32M
8.01%
-149.60M
96.01%
-114.50M
23.46%
-110.90M
3.14%
-78.40M
29.31%
-339M
332.40%
-642.40M
89.50%
net cash provided by operating activities
-8.08M
-
-457.01M
5,558.68%
569.89M
224.70%
383.09M
32.78%
87.90M
77.05%
549.80M
525.48%
874.20M
59.00%
1.05B
19.86%
1.01B
3.80%
582.98M
42.16%
investments in property plant and equipment
-216.34M
-
-238.05M
10.04%
-90.45M
62.00%
-56.35M
37.70%
-62.80M
11.44%
-186.90M
197.61%
-142.20M
23.92%
-77.10M
45.78%
-96.20M
24.77%
-85.20M
11.43%
acquisitions net
2.70M
-
4.90M
81.48%
24.20M
393.88%
32.50M
34.30%
34.80M
7.08%
purchases of investments
-110.80M
-
-330M
197.83%
-1.69B
412.12%
-1.71B
1.43%
sales maturities of investments
89.71K
-
446.80M
-
-4.90M
101.10%
1.69B
34,589.80%
other investing activites
70.64M
-
51.61M
26.93%
54.39M
5.38%
58.79M
8.09%
80M
36.07%
110.20M
37.75%
124.20M
12.70%
1.81B
1,355.23%
111.10M
93.85%
231.46M
108.33%
net cash used for investing activites
-145.70M
-
-186.44M
27.96%
-36.06M
80.66%
2.53M
107.01%
-93.60M
3,804.06%
42.80M
145.73%
-1.71B
4,090.65%
1.73B
201.31%
47.40M
97.26%
181.06M
281.98%
debt repayment
-161.39K
-
-2.75M
-
common stock issued
common stock repurchased
dividends paid
-25M
-
-50M
100%
-50M
0%
-200M
300%
other financing activites
862.39M
-
-2.39M
-
-2.16M
9.91%
-38.60M
-
-39.70M
2.85%
-44.60M
12.34%
-44.84M
0.55%
net cash used provided by financing activities
862.23M
-
-5.15M
-
-2.16M
58.08%
-63.60M
-
-89.70M
41.04%
-94.60M
5.46%
-244.84M
158.82%
effect of forex changes on cash
8K
-
net change in cash
708.45M
-
-643.44M
190.82%
528.68M
182.16%
383.46M
27.47%
-5.70M
101.49%
592.60M
10,496.49%
-897.40M
251.43%
2.69B
399.58%
960.80M
64.26%
519.21M
45.96%
cash at beginning of period
168.32M
-
876.77M
420.89%
233.33M
73.39%
762.01M
226.59%
1.15B
50.33%
1.14B
0.50%
1.73B
51.99%
835M
51.80%
3.52B
321.96%
4.48B
27.27%
cash at end of period
876.77M
-
233.33M
73.39%
762.01M
226.59%
1.15B
50.32%
1.14B
0.49%
1.73B
51.99%
835M
51.80%
3.52B
321.96%
4.48B
27.27%
5.00B
11.58%
operating cash flow
-8.08M
-
-457.01M
5,558.68%
569.89M
224.70%
383.09M
32.78%
87.90M
77.05%
549.80M
525.48%
874.20M
59.00%
1.05B
19.86%
1.01B
3.80%
582.98M
42.16%
capital expenditure
-216.34M
-
-238.05M
10.04%
-90.45M
62.00%
-56.35M
37.70%
-62.80M
11.44%
-186.90M
197.61%
-142.20M
23.92%
-77.10M
45.78%
-96.20M
24.77%
-85.20M
11.43%
free cash flow
-224.41M
-
-695.06M
209.72%
479.44M
168.98%
326.73M
31.85%
25.10M
92.32%
362.90M
1,345.82%
732M
101.71%
970.70M
32.61%
911.80M
6.07%
497.78M
45.41%

All numbers in INR (except ratios and percentages)